Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Re: Design and endpoints of clinical trials in hepatocellular carcinoma.

× No keyword cloud information.

5 in total

1. Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients.

Authors: Song Gao; Peng-Jun Zhang; Jian-Hai Guo; Hui Chen; Hai-Feng Xu; Peng Liu; Ren-Jie Yang; Xu Zhu
Journal: World J Gastroenterol Date: 2015-09-28 Impact factor: 5.742

Review 2. Methodological assessment of HCC literature.

Authors: G Daniele; N Costa; V Lorusso; J Costa-Maia; I Pache; M Pirisi
Journal: Ann Oncol Date: 2013-04 Impact factor: 32.976

3. A -1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression.

Authors: Katja Piras-Straub; Khaleda Khairzada; Peri Kocabayoglu; Andreas Paul; Guido Gerken; Kerstin Herzer
Journal: Cancer Med Date: 2016-08-31 Impact factor: 4.452

4. Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma.

Authors: Hetong Zhao; Xiaofeng Zhai; Zhe Chen; Xuying Wan; Lanyu Chen; Feng Shen; Changquan Ling
Journal: Oncotarget Date: 2017-07-11

5. Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma.

Authors: Yunze Dong; Wei Zhai; Yunfei Xu
Journal: Transl Androl Urol Date: 2020-12

5 in total